Bilateral lung transplant for hereditary hemorrhagic telangiectasia in a pediatric patient

Pediatric Transplantation

Volumn 16, Issue 8, 2012, Pages

  Misra, Meghna V ^a   Mullen, Mary P ^b   Vargas, Sara O ^b   Kim, Heung Bae ^b   Boyer, Debra ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

hereditary hemorrhagic telangiectasia; pediatric lung transplantation; pediatrics; pulmonary hypertension

Indexed keywords

BARIUM; CYCLOSPORIN; EPSTEIN BARR VIRUS ANTIGEN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITRIC OXIDE; PREDNISONE; PROSTACYCLIN; RITUXIMAB; TACROLIMUS;

ARTICLE; BLOOD VESSEL BIOPSY; BRONCHIOLITIS OBLITERANS; BRONCHITIS; BRONCHOPNEUMONIA; CARDIOPULMONARY BYPASS; CASE REPORT; CHILD; COIL EMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE TITRATION; DYSPNEA; ENDOTHELIUM CELL; EPISTAXIS; EXERCISE TOLERANCE; EXTRACORPOREAL OXYGENATION; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL STATUS; GENERAL CONDITION DETERIORATION; GENETIC SCREENING; HEART ARREST; HEART CATHETERIZATION; HEART MURMUR; HEART RIGHT LEFT SHUNT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSIVE CRISIS; IMMUNOSUPPRESSIVE TREATMENT; LUNG ALVEOLUS MACROPHAGE; LUNG ARTERY PRESSURE; LUNG BIOPSY; LUNG FUNCTION TEST; LUNG GRAFT REJECTION; LUNG LOBE; LUNG SHUNTING; LUNG SURGERY; LUNG TRANSPLANTATION; LYMPH FOLLICLE; LYMPHOID TISSUE; MUTATIONAL ANALYSIS; NEUROSECRETORY CELL; OXYGEN SATURATION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRESCHOOL CHILD; PULMONARY ARTERIOVENOUS FISTULA; PULMONARY HYPERTENSION; PUVA; RENDU OSLER WEBER DISEASE; RETRANSPLANTATION; THORAX RADIOGRAPHY; VIRAL BRONCHIOLITIS; VITAL CAPACITY;

BRONCHIOLITIS OBLITERANS; CHILD, PRESCHOOL; ENDOTHELIAL CELLS; FEMALE; FOLLOW-UP STUDIES; GENES, DOMINANT; HUMANS; HYPERTENSION, PULMONARY; LUNG TRANSPLANTATION; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; TREATMENT OUTCOME;

EID: 84868707910     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2012.01717.x     Document Type: Article

References (17)

1. Shovlin CL, Letarte M,. Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: Issues in clinical management and review of pathogenic mechanisms. Thorax 1999: 54: 714-729.
2. Trembath RC, Thomson JR, Machado RD, et al., Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2001: 345: 325-334.
3. McDonald J, Bayrak-Todemir P, Pyeritz RE,. Hereditary hemorrhagic telangiectasia: An overview of diagnosis, management, and pathogenesis. Genet Med 2011: 13: 607-616.
4. Cottin V, Plauchu H, Bayle JY, Berthelet M, Revel D, Cordier JF,. Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. Am J Respir Crit Care Med 2004: 169: 994-1000.
5. Swanson KL, Prakash U, Stanson AW,. Pulmonary arteriovenous fistulas: Mayo Clinic experience, 1982-1997. Mayo Clin Proc 1999: 74: 671-680.
6. Svetliza G, De la Canal A, Beveraggi E, et al., Lung transplantation in a patient with arteriovenous malformations. J Heart Lung Transplant 2002: 21: 506-508.
7. Smoot LB, Obler D, McElhinney DB, et al., Clinical features of pulmonary arterial hypertension in young people with an ALK1 mutation and hereditary haemorrhagic telangiectasia. Arch Dis Child 2009: 94: 506-511.
8. Faughnan ME, Thabet A, Mei-Zahav M, et al., Pulmonary arteriovenous malformations in children: Outcomes of transcatheter embolectomy. J Pediatr 2004: 145: 826-831.
9. Pierucci P, Murphy J, Henderson KJ, Chyun DA, White RI Jr,., et al. New definition and natural history of patients with diffuse pulmonary arteriovenous malformations: Twenty seven-year experience. Chest 2008: 133: 653-661.
10. Kay JM,. Pulmonary vascular disease. In:, Churg AM, Myers JL, Tazelaar HD, Wright JL, eds. Thurlbeck's Pathology of the Lung, 3rd edn. New York: Thieme, 2005: 863-989.
11. Bucher U, Reid L,. Development of the intrasegmental bronchial tree: The pattern of branching and development of cartilage at various stages of intra-uterine life. Thorax 1961: 16: 207-218.
12. McAllister KA, Grogg KM, Johnson DW, et al., Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary hemorrhagic telangiectasia type 1. Nat Genet 1994: 8: 345-351.
13. Johnson DW, Berg JN, Baldwin MA, et al., Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 1996: 13: 189-195.
14. Prigoda NL, Savas S, Abdalla SA, et al., Hereditary haemorrhagic telangiectasia mutation detection, test sensitivity and novel mutations. J Med Genet 2006: 43: 722-728.
15. Olivieri C, Lanzarini L, Pagella F, et al., Echocardiographic screening discloses increased values of pulmonary artery systolic pressure in 9 of 68 unselected patients affected with hereditary hemorrhagic telangiectasia. Genet Med 2006: 8: 183-190.
16. Girerd B, Montani D, Coulet F, et al., Clinical outcomes of pulmonary artery hypertension in patients carrying an ACVRL1 (AKL1) mutation. Am J Respir Crit Care Med 2010: 181: 851-861.
17. Mullen MP,. Idiopathic and heritable pulmonary hypertension in children: New insights into causes evaluation and treatment advances in pulmonary hypertension. Advances in Pulmonary Hypertension 2011: 10: 104-108.